Literature DB >> 28421452

Susceptibility of Candida albicans from Cystic Fibrosis Patients.

Raquel Sabino1, Elisabete Carolino2, Richard B Moss3, Niaz Banaei4, Cristina Verissimo5, David A Stevens6,7.   

Abstract

Candida albicans is a common microbe, colonizer and potential pathogen found in respiratory cultures of cystic fibrosis (CF) patients. Because of possible development of resistance in patient isolates resulting from residence in the abnormal milieu of CF patient airways, or from exposure to antifungals, and considering the possibility of patient-to-patient spread of microbes and reports of elevated resistance to other fungal pathogens, it was important to assay the susceptibility of isolates of Candida and compare that profile to isolates from the community. In our center, and unlike another fungal pathogen, no increase in resistance of Candida isolates of the CF cohort was found.

Entities:  

Keywords:  Candida; Cystic fibrosis; Drug susceptibility; Fluconazole; Fungal pathogens

Mesh:

Substances:

Year:  2017        PMID: 28421452     DOI: 10.1007/s11046-017-0133-9

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  21 in total

1.  Anaerobic biofilm infections in cystic fibrosis.

Authors:  J William Costerton
Journal:  Mol Cell       Date:  2002-10       Impact factor: 17.970

2.  Sputum Candida albicans presages FEV₁ decline and hospital-treated exacerbations in cystic fibrosis.

Authors:  Sanjay H Chotirmall; Elaine O'Donoghue; Kathleen Bennett; Cedric Gunaratnam; Shane J O'Neill; Noel G McElvaney
Journal:  Chest       Date:  2010-05-14       Impact factor: 9.410

3.  High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole.

Authors:  Pierre-Régis Burgel; Marie-Thérèse Baixench; Michaël Amsellem; Etienne Audureau; Jeanne Chapron; Reem Kanaan; Isabelle Honoré; Jean Dupouy-Camet; Daniel Dusser; Corné H Klaassen; Jacques F Meis; Dominique Hubert; André Paugam
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

4.  Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance.

Authors:  Klaus Leth Mortensen; Rasmus Hare Jensen; Helle Krogh Johansen; Marianne Skov; Tacjana Pressler; Susan Julie Howard; Howard Leatherbarrow; Emilia Mellado; Maiken Cavling Arendrup
Journal:  J Clin Microbiol       Date:  2011-04-20       Impact factor: 5.948

5.  Association of chronic Candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis.

Authors:  Alex Gileles-Hillel; David Shoseyov; Itzhack Polacheck; Maya Korem; Eitan Kerem; Malena Cohen-Cymberknoh
Journal:  Pediatr Pulmonol       Date:  2015-09-18

6.  Stratified growth in Pseudomonas aeruginosa biofilms.

Authors:  Erin Werner; Frank Roe; Amandine Bugnicourt; Michael J Franklin; Arne Heydorn; Søren Molin; Betsey Pitts; Philip S Stewart
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

7.  Effect of Media Modified To Mimic Cystic Fibrosis Sputum on the Susceptibility of Aspergillus fumigatus, and the Frequency of Resistance at One Center.

Authors:  David A Stevens; Richard B Moss; Cathy Hernandez; Karl V Clemons; Marife Martinez
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

8.  High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.

Authors:  Florent Morio; Guillaume G Aubin; Isabelle Danner-Boucher; Alain Haloun; Emilie Sacchetto; Dea Garcia-Hermoso; Stéphane Bretagne; Michel Miegeville; Patrice Le Pape
Journal:  J Antimicrob Chemother       Date:  2012-05-11       Impact factor: 5.790

9.  IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis.

Authors:  Caroline G Baxter; Caroline B Moore; Andrew M Jones; A Kevin Webb; David W Denning
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

10.  Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide Formation.

Authors:  Elise S Cowley; Sebastian H Kopf; Alejandro LaRiviere; Wiebke Ziebis; Dianne K Newman
Journal:  MBio       Date:  2015-07-28       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.